{"id":54363,"date":"2026-03-18T18:50:05","date_gmt":"2026-03-18T18:50:05","guid":{"rendered":"https:\/\/www.europesays.com\/ch-fr\/54363\/"},"modified":"2026-03-18T18:50:05","modified_gmt":"2026-03-18T18:50:05","slug":"alcool-tabac-cocaine-comment-les-medicaments-antiobesite-pourraient-limiter-les-addictions","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch-fr\/54363\/","title":{"rendered":"Alcool, tabac, coca\u00efne… Comment les m\u00e9dicaments antiob\u00e9sit\u00e9 pourraient limiter les addictions"},"content":{"rendered":"

\n VU D\u2019AILLEURS – Les m\u00e9dicaments tels que le Wegovy auraient des effets contre la d\u00e9pendance \u00e0 la nicotine, au cannabis et aux opio\u00efdes.<\/p>\n

Par Romaric Haddou (Le Soir)<\/p>\n

Les\u00a0m\u00e9dicaments antiob\u00e9sit\u00e9<\/a>\u00a0comme le\u00a0Wegovy\u00a0<\/a>pourraient s\u2019av\u00e9rer utiles pour traiter les addictions. L\u2019id\u00e9e n\u2019est pas nouvelle, mais une \u00e9tude publi\u00e9e d\u00e9but mars dans le \u00ab British Medical Journal\u00bb confirme qu\u2019il pourrait y avoir un lien entre la prise de ces m\u00e9dicaments (dits \u00abanalogues du GLP-1\u00bb) et le risque de d\u00e9velopper une consommation probl\u00e9matique d\u2019alcool, de nicotine, de cannabis, de coca\u00efne ou d\u2019opio\u00efdes.<\/p>\n

Pour leur \u00e9tude, les chercheurs ont utilis\u00e9 deux cohortes compos\u00e9es de v\u00e9t\u00e9rans am\u00e9ricains souffrant de diab\u00e8te de type 2. Pour rappel, les GLP-1 ont d\u2019abord \u00e9t\u00e9 commercialis\u00e9s comme antidiab\u00e9tiques (ex: Ozempic) avant que leur notori\u00e9t\u00e9 n\u2019explose gr\u00e2ce \u00e0 leur efficacit\u00e9 antiob\u00e9sit\u00e9. Les scientifiques ont donc donn\u00e9 des GLP-1 au premier groupe et un autre type d\u2019antidiab\u00e9tique au second groupe.<\/p>\n

\n \u00c0 lire aussi
\n <\/p>\n

Les m\u00e9dicaments antiob\u00e9sit\u00e9 pourraient bien jouer un r\u00f4le contre l\u2019alcoolisme
\n <\/a>\n<\/p>\n

R\u00e9sultat\u00a0: les probl\u00e8mes d\u2019addiction ont \u00e9t\u00e9 plus rares dans le premier groupe. Les participants sans ant\u00e9c\u00e9dent addictif ont \u00e9t\u00e9 moins nombreux \u00e0 d\u00e9velopper\u2026<\/p>\n

\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 77% \u00e0 d\u00e9couvrir.\n <\/p>\n

\"Le<\/p>\n

Vente Flash<\/p>\n

-70% sur votre abonnement. Sans engagement.<\/p>\n

\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"VU D\u2019AILLEURS – Les m\u00e9dicaments tels que le Wegovy auraient des effets contre la d\u00e9pendance \u00e0 la nicotine,…\n","protected":false},"author":2,"featured_media":54364,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[14948,99,10131,1794,3457,2359,83,14950,10164,14949,1726,1686,4942,3251,1271,14945,14947,14946,84,23,8261],"class_list":{"0":"post-54363","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-actualite-sur-les-maladies","9":"tag-cancer","10":"tag-cardiologie","11":"tag-cerveau","12":"tag-diabete","13":"tag-diagnostic","14":"tag-health","15":"tag-info-sur-les-maladies","16":"tag-infographie","17":"tag-information-sur-les-maladies","18":"tag-maladie","19":"tag-medecine","20":"tag-medicament","21":"tag-medicaments","22":"tag-obesite","23":"tag-pathologie","24":"tag-pediatrie","25":"tag-psychiatrie","26":"tag-sante","27":"tag-suisse","28":"tag-traitement"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch_fr\/116251683924470041","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/54363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/comments?post=54363"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/posts\/54363\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media\/54364"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/media?parent=54363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/categories?post=54363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch-fr\/wp-json\/wp\/v2\/tags?post=54363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}